We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WEYS:NASDAQWeyco Group, Inc. Analysis

Data as of 2026-09-01 - not real-time

$44.77

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

At $44.77, Weyco Group, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. It has gained 15.3% over the past 30 days. With RSI at 57.4 the momentum picture is neutral, alongside a bearish MACD signal. The recent range runs from support at $40.54 up to resistance at $48.68.
Multiples put this in fair territory at a P/E of 12.3. Revenue is growing at 6.9% on a 12.4% profit margin. The 2.42% dividend yield looks covered by current payout levels.
Risk scores 7 out of 10, which is elevated for this asset class. With 30-day volatility of 31.4%, a beta of 0.87 and a maximum drawdown of 20.4%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 4 out of 10.

Top Market Events

Despite a decline in net sales, Weyco Group Inc WEYS showcases resilience with strong cash reserves, strategic supply...WEYCO Group, Inc. Second Quarter 2026 Earnings Conference Call. Milwaukee, WI, July 14, 2026 GLOBE NEWSWIRE -- WEYCO...Weyco Group Inc WEYS navigates tariff uncertainty with strategic inventory builds while strong brand momentum drives...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 34.84
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 34.84
  • MACD momentum is negative

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E ratio of 12.3
  • Dividend yield of 2.42%
  • Price-to-book of 1.65

Key Metrics & Analysis

Financial Health

Revenue Growth6.90%
Profit Margin12.39%
P/E Ratio12.3
ROE13.81%
ROA8.77%
Debt/Equity3.58
P/B Ratio1.7
Op. Cash Flow$48.1M
Free Cash Flow$39.5M

Technical Analysis

TrendBullish
RSI57.4
Support$40.54
Resistance$48.68
MA 20$45.16
MA 50$41.30
MA 200$34.84
MACDBearish
VolumeDecreasing
Fear & Greed Index93.18

Valuation

Fair Value$79.65
GradeFair
TypeBlend
Dividend Yield2.42%

Risk Assessment

Beta0.87
Volatility31.41%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.